title: Ethics and hepatitis B cure research.
authors.affiliation: Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, USA.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Sugarman
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Revill
authors.affiliation: INSERM, Cancer Research Center of Lyon, Hospices Civils de Lyon, Lyon University, Lyon, France.
authors.forename: Fabien
authors.initials: F
authors.lastname: Zoulim
authors.affiliation: INSERM, Infection Antimicrobials Modelling Evolution, University of Paris Diderot, Hôpital Bichat, Paris, France.
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
authors.affiliation: Toronto Centre for Liver Disease, University Health Network, Toronto General Hospital, Toronto, Canada.
authors.forename: Harry L A
authors.initials: HL
authors.lastname: Janssen
authors.affiliation: Division of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.
authors.forename: Seng Gee
authors.initials: SG
authors.lastname: Lim
authors.affiliation: The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
authors.forename: Sharon R
authors.initials: SR
authors.lastname: Lewin
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D035843:Biomedical Research / Q000941:ethics; D002986:Clinical Trials as Topic / Q000941:ethics; D004359:Drug Therapy, Combination; D014943:Global Health; D019694:Hepatitis B, Chronic / Q000401:mortality / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D018579:Patient Selection; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors
keywords: CHRONIC HEPATITIS; CIRRHOSIS; CLINICAL TRIALS; HEPATITIS B; HEPATOCELLULAR CARCINOMA